Procter & Gamble Health (BOM:500126) Total Inventories: ₹1,367 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500126 Procter & Gamble Health Ltd BOM:500126
86 GF Score
Price ₹6,797.90
GF Value ₹6,049.27
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Procter & Gamble Health Total Inventories?

Procter & Gamble Health BOM:500126 -0.76% 86 Total Inventories is ₹1,367 Mil as of Mar. 2026. GuruFocus rates BOM:500126 with a GF Score™ of 86/100 and a GF Value™ of ₹6,049.27 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Procter & Gamble Health's total inventories for the quarter that ended in Mar. 2026 was ₹1,367 Mil. Procter & Gamble Health's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ₹683 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Procter & Gamble Health's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹45.89.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Procter & Gamble Health's Days Inventory for the three months ended in Mar. 2026 was 67.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. Procter & Gamble Health's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Procter & Gamble Health's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.18.


Procter & Gamble Health  (BOM:500126) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Procter & Gamble Health's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is

Net-Net Working Capital Per Share (Q: Mar. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2014.6+0.75 * 1642.6+0.5 * 1366.5-3168
-0-0)/16.599
=45.89

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Procter & Gamble Health's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=683.25/928.7*365 / 4
=67.13

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Procter & Gamble Health's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=928.7 / 683.25
=1.36

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Procter & Gamble Health's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=683.25 / 3704.5
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Procter & Gamble Health Total Inventories Related Terms


Procter & Gamble Health Total Inventories Historical Data

* Premium members only.

The historical data trend for Procter & Gamble Health's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Health Total Inventories Chart

Procter & Gamble Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Jun21 Jun22 Jun23 Jun24
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,143.24 1,183.70 1,152.10 1,349.40 1,091.10

Procter & Gamble Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1,273.30 0.00 1,366.50
BOM:500126
86GF Score
Procter & Gamble Health Ltd BOM:500126
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procter & Gamble Health Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of ₹1,367 Mil mean?
Procter & Gamble Health (BOM:500126) has a Total Inventories of ₹1,367 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Procter & Gamble Health and its competitors.
Is Procter & Gamble Health's Total Inventories too high?
Procter & Gamble Health's current Total Inventories is ₹1,367 Mil. Overall, Procter & Gamble Health has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Health's Total Inventories compare to ZTS and UTHR?
Procter & Gamble Health's Total Inventories of ₹1,367 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Procter & Gamble Health and its competitors. Procter & Gamble Health's current Total Inventories is ₹1,367 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Health stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Health (BOM:500126) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6,049.27, compared to a current price of ₹6,797.90 — trading 12.4% above its estimated fair value. The current Total Inventories is ₹1,367 Mil. Procter & Gamble Health's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Procter & Gamble Health (BOM:500126), the current Total Inventories is ₹1,367 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Procter & Gamble Health (BOM:500126) Overvalued in 2026?

Based on GuruFocus' analysis, Procter & Gamble Health stock appears to be overvalued. The current stock price of ₹6,797.90 is trading 12.4% above its estimated GF Value™ of ₹6,049.27. GuruFocus considers Procter & Gamble Health to be Modestly Overvalued.

Key valuation signals for BOM:500126:

  • Total Inventories: ₹1,367 Mil
  • GF Value™: ₹6,049.27 vs. price of ₹6,797.90 (12.4% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the BOM:500126 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Procter & Gamble Health Business Description

Other Exchanges PGHL:India
Address Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
86GF Score

Get the complete analysis for BOM:500126

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,797.90
Price
₹6,049.27
GF Value